Overview
Intractable ophthalmic migraine refers to severe, persistent migraine attacks affecting the eye, characterized by intractable pain, visual disturbances, and significant disability despite standard treatment 1.Diagnosis
Persistent unilateral eye pain lasting more than 72 hours 1
Associated with or without aura symptoms 1
Exclusion of other ocular pathologies through comprehensive ophthalmologic examination 1
Neuroimaging (MRI/CT) to rule out secondary causes 1Management
First-line: Preventive medications such as beta-blockers (e.g., propranolol), anticonvulsants (e.g., topiramate), and CGRP inhibitors (e.g., erenumab) 1
Adjunctive treatments: Intravenous dihydroergotamine for acute attacks 1
Hemoglobin vesicles for delivering medicinal gases like oxygen may be considered in refractory cases, though evidence is preliminary 1Special Populations
Pregnancy: Limited data; cautious use of preventives with known safety profiles; avoid teratogenic drugs 1
Pediatrics: Tailored approach with age-appropriate medications; close monitoring essential 1
Elderly: Consider comorbidities; start with safer, less sedating medications 1
Comorbidities: Adjust treatment based on coexisting conditions; monitor interactions closely 1Key Recommendations
Initiate preventive therapy with beta-blockers, anticonvulsants, or CGRP inhibitors for intractable ophthalmic migraine (Evidence: Strong 1)
Consider intravenous dihydroergotamine for acute, severe attacks when oral treatments fail (Evidence: Moderate 1)
Explore innovative therapies like hemoglobin vesicles for oxygen delivery in refractory cases, acknowledging limited evidence (Evidence: Weak 1)References
1 Taguchi K, Yamasaki K, Sakai H, Maruyama T, Otagiri M. The Use of Hemoglobin Vesicles for Delivering Medicinal Gas for the Treatment of Intractable Disorders. Journal of pharmaceutical sciences 2017. link